Sciclone Pharmaceuticals Inc (SCLN) financial statements (2022 and earlier)

Company profile

Business Address 950 TOWER LANE
FOSTER CITY, CA 94404-2125
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments134,395101,40386,30385,80384,228
Cash and cash equivalents134,395101,40386,22885,80384,228
Short-term investments  75  
Restricted cash and investments   752,759
Receivables41,51039,36340,26840,00838,109
Inventory, net of allowances, customer advances and progress billings16,58710,97610,70315,23810,424
Inventory16,58710,97610,70315,23810,424
Prepaid expense and other current assets2,2871,809
Deferred tax assets 299326  
Other undisclosed current assets3,24116,4802,597  
Total current assets:195,733168,521140,197143,411137,329
Noncurrent Assets
Property, plant and equipment2,0022,6511,8488431,377
Long-term investments and receivables  4,750  
Accounts and financing receivable, after allowance for credit loss  4,750  
Intangible assets, net (including goodwill)30,83832,97934,52135,35734,313
Goodwill30,83832,97934,52135,35734,313
Other noncurrent assets12,53112,468  
Other undisclosed noncurrent assets794 5156161,052
Total noncurrent assets:46,16548,09841,63436,81636,742
TOTAL ASSETS:241,898216,619181,831180,227174,071
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities26,44136,64635,23133,68333,624
Accounts payable3,6454,4955,3117,1907,787
Accrued liabilities22,79632,15120,53621,46421,427
Employee-related liabilities  4,176  
Taxes payable  5,2085,0294,410
Debt   1,6511,445
Deferred revenue and credits 1745962,915 
Deferred tax liabilities   368153
Total current liabilities:26,44136,82035,82738,61735,222
Noncurrent Liabilities
Liabilities, other than long-term debt9287   
Other liabilities9287   
Total noncurrent liabilities:9287   
Total liabilities:26,53336,90735,82738,61735,222
Stockholders' equity
Stockholders' equity attributable to parent215,365179,712155,274146,595143,022
Common stock5150505254
Additional paid in capital304,599296,086287,108278,327274,387
Accumulated other comprehensive income (loss)(1,520)2,0703,2644,1762,988
Accumulated deficit(87,765)(118,494)(135,148)(135,960)(134,407)
Total stockholders' equity:215,365179,712155,274146,595143,022
Other undisclosed liabilities and equity  (9,270)(4,985)(4,173)
TOTAL LIABILITIES AND EQUITY:241,898216,619181,831180,227174,071

Income statement (P&L) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues160,096157,257134,790127,058156,269
Revenue, net155,937154,329131,97399,414123,171
Cost of revenue(36,990)(44,013)(1,574)  
Cost of goods and services sold(34) (1,574)  
Gross profit:123,106113,244133,216127,058156,269
Operating expenses(89,871)(83,333)(72,101)(92,898)(96,318)
Other undisclosed operating loss  (35,131)(23,731)(53,541)
Operating income:33,23529,91125,98410,4296,410
Nonoperating income (expense)8983593932,777(42)
Foreign currency transaction loss, before tax(2,200)(400)   
Other nonoperating income (expense)(164)(510)2802,795(42)
Other undisclosed loss from continuing operations before equity method investments, income taxes    (96)
Income from continuing operations before income taxes:34,13330,27026,37713,2066,272
Income tax expense (benefit)(3,404)(807)(1,169)(2,242)3,348
Net income available to common stockholders, diluted:30,72929,46325,20810,9649,620

Comprehensive Income ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income:30,72929,46325,20810,9649,620
Other comprehensive income (loss)  (912)1,188644
Comprehensive income:30,72929,46324,29612,15210,264
Other undisclosed comprehensive loss, net of tax, attributable to parent(3,590)(1,194)   
Comprehensive income, net of tax, attributable to parent:27,13928,26924,29612,15210,264

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: